Ann Neurol

1. CALABRESE M, Preziosa P, Scalfari A, Colato E, et al
   Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis.
   Ann Neurol. 2024 Apr 3. doi: 10.1002/ana.26913.
   

   >> Share

   
   
2. NEIDHART S, Vlad B, Hilty M, Hogelin KA, et al
   HLA Associations of Intrathecal IgG Production against Specific Viruses in Multiple Sclerosis.
   Ann Neurol. 2024 Mar 29. doi: 10.1002/ana.26921.
   

   >> Share

   
   

   
   BMC Neurol

3. WANNINAYAKE L, Rajapaksha D, Nair N, Gunarathne K, et al
   Guillain-Barre syndrome of acute motor axonal neuropathy (AMAN) type associated with herpes zoster: a case report.
   BMC Neurol. 2024;24:109.
   

   >> Share

   
   
4. CARDENAS-ROBLEDO S, Arenas-Vargas LE, Arenas RD, Gaspar-Toro JM, et al
   Treatment patterns and persistence on disease modifying therapies for multiple sclerosis and its associated factors.
   BMC Neurol. 2024;24:108.
   

   >> Share

   
   

   
   Intern Med

5. ISOGAI S, Hayashi R, Naniwa T
   Nasal Septal Perforation and Widespread Skin Lesions caused by Mycobacterium chelonae Infection Mimicking Granulomatosis with Polyangiitis.
   Intern Med. 2023 Aug 9. doi: 10.2169/internalmedicine.2202.
   

   >> Share

   
   
6. IWATA F, Fukui S, Okada M
   Herpes Esophagitis Occurring after Immunosuppression with Glucocorticoids.
   Intern Med. 2024;63:1033-1034.
   

   >> Share

   
   
7. MIZUTANI K, Sakurai K, Uchida Y, Hashimoto K, et al
   A case of autoimmune encephalitis in a patient with a solitary intracranial plasmacytoma.
   Intern Med. 2024 Apr 2. doi: 10.2169/internalmedicine.2888.
   

   >> Share

   
   
8. OKABAYASHI H, Nakashima S, Fujino K, Imai M, et al
   Tension Pneumomediastinum in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease: A Case Report and Literature Review.
   Intern Med. 2024 Apr 2. doi: 10.2169/internalmedicine.3418.
   

   >> Share

   
   

   
   J Autoimmun

9. BENDER C, Muller P, Tondello C, Horn J, et al
   Gene-expression profiling of laser-dissected islets and studies in deficient mice reveal chemokines as differential driving force of type 1 diabetes.
   J Autoimmun. 2023;143:103161.
   

   >> Share

   
   
10. ZHONG T, Li X, Lei K, Tang R, et al
    CXCL12-CXCR4 mediates CD57(+) CD8(+) T cell responses in the progression of type 1 diabetes.
    J Autoimmun. 2024;143:103171.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

11. VILLAGELIN D, Cooper DS, Burch HB
    A 2023 International Survey of Clinical Practice Patterns in the Management of Graves' Disease: A Decade of Change.
    J Clin Endocrinol Metab. 2024 Apr 5:dgae222. doi: 10.1210.
    

    >> Share

    
    

    
    J Immunol

12. FRANK C, Salapa HE, Allen KJH, Levin MC, et al
    Antibody-Mediated Depletion of Autoreactive T Lymphocytes through PD-1 Improves Disease Outcomes and Visualizes T Cell Activation in Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2024 Apr 5:ji2300751. doi: 10.4049/jimmunol.2300751.
    

    >> Share

    
    

    
    J Neuroimmunol

13. SRIWASTAVA S, Elkhooly M, Amatya S, Shrestha K, et al
    Recent advances in the treatment of primary and secondary progressive Multiple Sclerosis.
    J Neuroimmunol. 2024;390:578315.
    

    >> Share

    
    

    
    J Neurol

14. HUA T, Fan H, Duan Y, Tian D, et al
    Spinal cord and brain atrophy patterns in neuromyelitis optica spectrum disorder and multiple sclerosis.
    J Neurol. 2024 Apr 1. doi: 10.1007/s00415-024-12281.
    

    >> Share

    
    
15. GLASER A, Butzkueven H, van der Walt A, Gray O, et al
    Big Multiple Sclerosis Data network: an international registry research network.
    J Neurol. 2024 Apr 1. doi: 10.1007/s00415-024-12303.
    

    >> Share

    
    
16. GUERRIERI S, Rubin M, Gattuso I, Zanetta C, et al
    Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series.
    J Neurol. 2024 Apr 2. doi: 10.1007/s00415-024-12342.
    

    >> Share

    
    
17. SIGNORIELLO E, Foschi M, Lanzillo R, Frau J, et al
    Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine.
    J Neurol. 2024 Apr 3. doi: 10.1007/s00415-024-12291.
    

    >> Share

    
    
18. MAIDA E, Moccia M, Palladino R, Borriello G, et al
    ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis.
    J Neurol. 2024 Apr 3. doi: 10.1007/s00415-024-12328.
    

    >> Share

    
    
19. TERAYAMA A, Kuwahara M, Yoshikawa K, Yamagishi Y, et al
    Takotsubo cardiomyopathy in Guillain-Barre syndrome.
    J Neurol. 2024 Apr 4. doi: 10.1007/s00415-024-12295.
    

    >> Share

    
    
20. STEFANOU MI, Giannopapas V, Kitsos DK, Chondrogianni M, et al
    Prevalence and epidemiology of stroke in patients with multiple sclerosis: a systematic review and meta-analysis.
    J Neurol. 2024 Apr 4. doi: 10.1007/s00415-024-12331.
    

    >> Share

    
    
21. CELIK M, Baba C, Irmak C, Ozakbas S, et al
    Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey.
    J Neurol. 2024 Apr 5. doi: 10.1007/s00415-024-12333.
    

    >> Share

    
    
22. MARTINEZ-MARTINEZ L, Lacruz AC, Querol L, Cortes-Vicente E, et al
    Inter-laboratory comparison of routine autoantibody detection methods for autoimmune neuropathies and myasthenia gravis.
    J Neurol. 2024 Apr 5. doi: 10.1007/s00415-024-12317.
    

    >> Share

    
    

    
    J Rheumatol

23. ROBERTS JE, Faino A, Bryan MA, Cogen JD, et al
    Hospitalization and Mortality due to Infection among United States Children and Adolescents with Systemic Lupus Erythematosus.
    J Rheumatol. 2024 Apr 1:jrheum.2023-1219. doi: 10.3899/jrheum.2023-1219.
    

    >> Share

    
    
24. JUNEK M, Barra L, Kopp A, Felfeli T, et al
    Phase Specific Health Care Costs Associated with Giant Cell Arteritis in Ontario, Canada.
    J Rheumatol. 2024 Apr 1:jrheum.2023-1245. doi: 10.3899/jrheum.2023-1245.
    

    >> Share

    
    
25. CONTRERAS MARTIN GN
    Lupus Nephritis Treatment Strategies.
    J Rheumatol. 2024 Apr 1:jrheum.2024-0172. doi: 10.3899/jrheum.2024-0172.
    

    >> Share

    
    
26. OWN M, Bloostein A, Spiera R, Berman JR, et al
    Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero Rescue and Recovery Efforts: A Case Series.
    J Rheumatol. 2024;51:390-395.
    

    >> Share

    
    
27. SEMALULU T, Berard R, Beattie K, Basodan D, et al
    Clinical Characteristics of Adolescents With Juvenile Idiopathic Arthritis Transitioning to Adult Rheumatology Care in Canada: Results From the CAPRI Registry.
    J Rheumatol. 2024;51:403-407.
    

    >> Share

    
    

    
    Kidney Int

28. BELLUR SS, Troyanov S, Vorobyeva O, Coppo R, et al
    Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
    Kidney Int. 2024 Mar 28:S0085-2538(24)00235-7. doi: 10.1016/j.kint.2024.
    

    >> Share

    
    
29. LAFAYETTE R, Barbour S, Israni R, Wei X, et al
    A Phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy.
    Kidney Int. 2024 Mar 27:S0085-2538(24)00236-9. doi: 10.1016/j.kint.2024.
    

    >> Share

    
    

    
    Mult Scler

30. KWON S, Han KD, Jung JH, Cho EB, et al
    Risk of depression and anxiety in multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study in South Korea.
    Mult Scler. 2024 Apr 1:13524585241237093. doi: 10.1177/13524585241237093.
    

    >> Share

    
    
31. PAPPOLLA A, Auger C, Sao-Aviles A, Tur C, et al
    Prediction of disease activity and treatment failure in relapsing-remitting MS patients initiating daily oral DMTs.
    Mult Scler. 2024 Mar 29:13524585241240653. doi: 10.1177/13524585241240653.
    

    >> Share

    
    

    
    Neurologia (Engl Ed)

32. RAMOS-GONZALEZ EJ, Bitzer-Quintero OK, Ortiz G, Hernandez-Cruz JJ, et al
    Relationship between inflammation and oxidative stress and its effect on multiple sclerosis.
    Neurologia (Engl Ed). 2024;39:292-301.
    

    >> Share

    
    

    
    Neurology

33. OYAMA M, Holzer MT, Ohnuki Y, Saito Y, et al
    Pathologic Features of Anti-Ku Myositis.
    Neurology. 2024;102:e209268.
    

    >> Share

    
    

    
    PLoS One

34. IMRAISH A, Abu Thiab T, Alsalem M, Dahbour S, et al
    The neuroprotective effect of human primary astrocytes in multiple sclerosis: In vitro model.
    PLoS One. 2024;19:e0300203.
    

    >> Share

    
    
35. ESIASON DC, Ciesinski N, Nurse CN, Erler W, et al
    The psychological burden of NMOSD - a mixed method study of patients and caregivers.
    PLoS One. 2024;19:e0300777.
    

    >> Share

    
    
36. KAMPAITE A, Gustafsson R, York EN, Foley P, et al
    Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic review.
    PLoS One. 2024;19:e0299634.
    

    >> Share

    
    
37. MA J, Xing J, Zhang Y, Liu G, et al
    Efficacy and safety of biologic agents for IgA nephropathy: A protocol for systematic review and meta-analysis.
    PLoS One. 2024;19:e0298732.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share